-
EP3897570
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3897570
| EP3897570 - PHARMACEUTICAL COMPOSITION COMPRISING GLP-1 ANALOGUE [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 29.04.2022 Database last updated on 07.04.2026 | |
| Former | Request for examination was made Status updated on 24.09.2021 | ||
| Former | The international publication has been made Status updated on 02.07.2020 | ||
| Former | unknown Status updated on 10.01.2020 | Most recent event Tooltip | 29.04.2022 | Withdrawal of application | published on 01.06.2022 [2022/22] | Applicant(s) | For all designated states KRKA, d.d., Novo mesto Smarjeska cesta 6 8501 Novo mesto / SI | [2021/43] | Inventor(s) | 01 /
ROZMAN, Sasa Bohoriceva ulica 15 8270 Krsko / SI | 02 /
KOLESA DOBRAVC, Tanja Gornja Prekopa 10B 8311 Kostanjevica na Krki / SI | 03 /
SLADIC, Gordan Ulica Pie in Pina Mlakarja 39 8000 Novo Mesto / SI | 04 /
VIDIC, Iztok Hrenova Ulica 17 1000 Ljubljana / SI | 05 /
LIN, Haowen c/o Hybio Pharmaceutical Co., Ltd. No. 37, Keji C. 2nd St. Shenzhen Hi-tech Industrial Park 518057 Guangdong / CN | 06 /
HE, Guotao c/o Hybio Pharmaceutical Co., Ltd. No. 37, Keji C. 2nd St. Shenzhen Hi-tech Industrial Park 518057 Guangdong / CN | 07 /
QIN, Liangzheng c/o Hybio Pharmaceutical Co., Ltd. No. 37, Keji C. 2nd St. Shenzhen Hi-tech Industrial Park 518057 Guangdong / CN | [2021/43] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2021/43] | Application number, filing date | 19829134.6 | 18.12.2019 | [2021/43] | WO2019EP85942 | Priority number, date | SI20180000275 | 19.12.2018 Original published format: SI 201800275 | SI20190000172 | 12.09.2019 Original published format: SI 201900172 | [2021/43] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020127476 | Date: | 25.06.2020 | Language: | EN | [2020/26] | Type: | A1 Application with search report | No.: | EP3897570 | Date: | 27.10.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.06.2020 takes the place of the publication of the European patent application. | [2021/43] | Search report(s) | International search report - published on: | EP | 25.06.2020 | Classification | IPC: | A61K9/00, A61K38/26 | [2021/43] | CPC: |
A61K9/0019 (EP);
A61K38/26 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/43] | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT GLP-1-ANALOG | [2021/43] | English: | PHARMACEUTICAL COMPOSITION COMPRISING GLP-1 ANALOGUE | [2021/43] | French: | COMPOSITION PHARMACEUTIQUE COMPRENANT UN ANALOGUE DE GLP -1 | [2021/43] | Entry into regional phase | 19.07.2021 | National basic fee paid | 19.07.2021 | Designation fee(s) paid | 19.07.2021 | Examination fee paid | Examination procedure | 19.07.2021 | Examination requested [2021/43] | 19.07.2021 | Date on which the examining division has become responsible | 08.03.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 28.04.2022 | Application withdrawn by applicant [2022/22] | Fees paid | Renewal fee | 21.12.2021 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI] WO2006051110 (NOVO NORDISK AS et al.) | [X] WO2016038521 (SUN PHARMACEUTICAL IND LTD et al.) | [X] WO2018096460 (BIOCON RES LIMITED et al.) | [XP] WO2019038412 (NOVO NORDISK AS et al.) | by applicant | WO03002136 | WO2004105781 | WO2004105790 | WO2005049061 | EP2494983 | WO2007146448 | CN102429876 | CN110368376 | CN110339166 | WO2016038521 | WO2017147783 | WO2018096460 | WO2019193204 | WO2019110837 | EP2494983 | WO9943705 | US6268343 | US7273921 | US6451974 | WO0055119 | WO2005019261 | WO2005019262 | WO2005058954 | WO2007090496 | WO2010029159 | WO2013037266 | WO2013117135 | CN104045705 | CN104045706 | CN103275208 | WO2014199397 | CN103288951 | CN103304659 | CN103304660 | CN103087181 | WO2015100876 | CN103864918 | CN104004083 | WO2016005960 | WO2016046753 | WO2016059609 | WO2016067271 | CN104650219 | CN104745597 | WO2017007324 | CN105017381 | CN106478805 | CN105732798 | CN105294853 | WO2017138855 | WO2017162650 | CN107286234 | WO2018020417 | WO2018032521 | CN106397573 | WO2018104922 | CN106699871 | CN107056927 | CN107022021 | WO2006097537 | "Remington: The Science and Practice of Pharmacy", 2013 |